Introduction
Preeclampsia is a complex multipathway disease process diagnosed by hypertension with two readings of systolic blood pressure ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg, separated by a 4-6 hour period, and proteinuria with a urine dipstick of ≥ 1+ or ≥ 300 mg per 24 hours, after 20 weeks' gestation in a previously normotensive patient. Eclampsia, new onset of grand mal seizures during or after pregnancy without any other identifiable cause is one risk that can follow the diagnosis of pre-eclampsia. The overall risk of seizure is 1%, and is preventable with use of Magnesium Sulfate in women with severe preeclampsia, such as this patient. Severe preeclampsia is defined as a systolic BP ≥ 160 mmHg or diastolic BP ≥ 110 mmHg, measured twice at least 6 hours apart or evidence of other end organ damage, including presence of renal failure, liver dysfunction, central nervous system disturbance, pulmonary edema, or right upper quadrant pain.
Ninety-nine percent of pregnancy related deaths occur in middle and lowincome countries (LMIC). Of these deaths, the World Health Organization (WHO) ranks pre-eclampsia and eclampsia as the second leading direct cause of maternal morbidity and mortality, behind only postpartum hemorrhage.
A woman born in a developing country has a seven times greater risk of developing pre-eclampsia and a three times greater risk of progressing to eclampsia. Within the realm of eclampsia, she has roughly a fourteen times greater risk of death. Additionally, infant mortality in women with preeclampsia is 3 times higher in LMIC than in high-income countries. While this journal's special issue addresses advancements in our scientific understanding of preeclampsia, this paper seeks to review what we know about the basics of detection and management to encourage thoughtful applications in improving the global burden of preeclampsia and eclampsia in low resources settings.
Access Limitations
The The majority of maternal morbidity and mortality is due to limited access of prenatal care and obstetrical intervention. In high-income countries, 98% of women report having at least one prenatal visit, compared to only 68% in LMIC.
A further dichotomy exists in rural vs urban settings worldwide. The WHO sets a standard goal of at least four prenatal visits. Only 61% of women in urban areas and 39% of women in rural areas meet this goal. Common barriers to care include traveling long distances, fees, childcare, financial autonomy, and a shortage of providers, especially female. These same barriers prevent women from delivering at a health facility. A survey in 41 LMIC showed that nearly a quarter of women said they did not go to the health facility for delivery because a male provider staffed it.
Even among the 68% of women obtaining a prenatal visit, further barriers exist in diagnostics. One study found that 15-30% of women obtaining prenatal care never had their blood pressure checked. The WHO recommends urine dipsticks for proteinuria only in nulliparous women or those with a history of pre-eclampsia. Limitations in proper point of care testing include cost and availability of dipsticks, as well as proper training and equipment to accurately measure blood pressure. Diagnostic limitations mean that a careful physical exam and early recognition of physical findings is vital in these situations. Educating women and midlevel community providers to recognize acute onset edema may reduce complications and delays. One interesting "mom-edema-meter" prototype has been proposed in the form of a wristband that is comfortable yet snug enough to quantify expansion caused by edema. When specified measurements are reached, the woman has been told to seek further medical care.
Diagnostics

HW noticed swelling in her hands and feet several weeks ago, but a community elder told her it was normal and gave her an herbal tea to help the
Another effective strategy in diagnosis is utilizing community health workers as liaisons between rural communities and nearby hospitals. Community health workers are lay members of the community who work within the local health system with the advantage of working more intimately with community members and sharing cultural traditions. If they can be trained and equipped to obtain basic pressure and protein studies at home visits, they can work within the local health system and prearrange necessary triage and transport. Even when pre-eclampsia is diagnosed, further hurdles exist in obtaining the necessary emergent interventions. If community health workers serve as the first point of contact for many women, the ideal antihypertensive treatment would be an oral medication with one time dosing. Insufficient evidence exists to support use of oral medication in severe hypertension of pregnancy. Even notoriously cheap and effective magnesium sulfate is underutilized due to limited supply, limited provider knowledge and training, fear of administration due to limited monitoring, and lack of national protocols. Evidence-based information dissemination is needed.
Prevention
Without adequate antenatal care and imaging, effective prevention strategies
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are of great value. Aspirin is associated with a 10-19% reduction in preeclampsia, and a 10-16% decrease in perinatal morbidity and mortality in women determined to be at "moderate to high risk" by their medical, obstetric, and family histories as well as ultrasound findings. Identifying these moderate-high risk groups may be difficult, as most women have at least one risk factor (both multiparity and nulliparity are listed as risks). Even this small reduction in incidence has the potential to make a great impact on women who may otherwise have no monitoring. The low cost and safety profile of the drug are encouraging for application in routine OB care in low resource settings. There is some evidence to suggest a preventative role for calcium, especially in nutrient deficient women with hypocalcaemia at baseline. Randomized controlled trials are underway, and several initiatives have been proposed to refine the large, chalky tablets into a lower-cost, smaller, and more appetizing version. In Haiti, over-the-counter "Tums" are more readily available and comfortably utilized in both market and clinical settings. These small preventative measures have the potential to make a large impact on patients like the one featured in this article.
Conclusions
HW was carried unwillingly into the back of a truck, where an IV was started to administer fluids and magnesium sulfate. 40 minutes of bumpy driving with the sick mother finally paid off when they reached the Cuban physician staffing the public clinic. Fortunately, her blood pressure was controlled with IV labetolol; she was continued on magnesium and had no further seizures. She vaginally delivered a small baby boy, and was able to follow up with the CHAs for blood pressure checks each week.
The need for prevention, detection, and treatment of pre-eclampsia is immense, especially in low income countries like Haiti. While Iowa City boasts 52 physicians per 10,000 people, in Haiti (just a several hour flight away) the ratio is 10 physicians per 10,000 people. Haitian obstetrical practices and maternal and infant health are particularly concerning. During childbirth, only 1/4 Haitian women will have a "skilled" attendant at her side, and three of every 1000 will die during the process.
We have developed amazing technologies in the field of women's health, but if only a few women have access to them, are we really doing a service to women of the world? Few interventions have a greater impact than basic prenatal care: a physical exam in educated hands, cheap medications, and diagnostics as simple as a sphygmomanometer and urine dipsticks. As women's health professionals, we must be more proactive in sharing our wealth of educational opportunities and advocating for the underserved women of the world.
Biography
Rachel Bender is a fourth year medical student at the University of Iowa, pursuing a career in Ob-Gyn with an interest in international women's health. She has been active in a locally grown organization called "Community Health Initiative, Haiti" (CHI) which is dedicated to meeting the health needs of 5 underserved Haitians. CHI visits the same Haitian communities every three months with a full medical team, and pays monthly stipends to five local women to work as Community Health Agents to deliver basic health education and services. The urgency and danger of the case profiled in this article hit close to home for Rachel and other CHI providers, sparking a drive to push for more aggressive prenatal care measures. Rachel and CHI colleagues have worked closely with these women to perform and document at least four routine prenatal home visits equipped with urine dipsticks, blood pressure cuffs, and knowledge. CHI is working to obtain evidence to support these measures, and has recently launched a new electronic medical records system for use at quarterly clinics. A long-term goal is to incorporate data from health worker home visits into the system for improved patient monitoring.
CHI offers opportunities for health professionals and students to share their talents through clinical service and community education. All local community members are welcome to be involved in the Community Health Initiative, lead locally by UI physicians Dr. Chris Buresh, Dr. Ginny Ryan, and a supporting group of students. Please contact CHI or Rachel if you are interested in getting more involved! Community Health Initiative, Haiti www.Chihaiti.com chi.uiowa@gmail.com
